Blood-Clot Drug Buyers Seek Class Cert. In Antitrust Suit

By Matthew Perlman · November 19, 2018, 8:11 PM EST

Indirect purchasers of blood clot drug Lovenox and its generic version asked a Tennessee federal court for class certification in their suit alleging Momenta Pharmaceuticals Inc. and Sandoz Inc. conspired to...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

The Hospital Authority of Metropolitan Government of Nashville and Davidson County, Tennessee v. Momenta Pharmaceuticals, Inc. et al

Case Number

3:15-cv-01100

Court

Tennessee Middle

Nature of Suit

Anti-Trust

Date Filed

October 14, 2015